Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery.
about
Recent advances in oral vaccine development: yeast-derived β-glucan particlespH-Responsive nanoparticles for drug delivery.Nanoparticle strategies for the oral delivery of insulin.Engineering strategies to enhance nanoparticle-mediated oral delivery.Chitosan nanoparticles: a survey of preparation methods.Drug transport mechanism of oral antidiabetic nanomedicines.Oral insulin delivery systems using chitosan-based formulation: a review.Nanolayer encapsulation of insulin-chitosan complexes improves efficiency of oral insulin delivery.Chitosan-zinc-insulin complex incorporated thermosensitive polymer for controlled delivery of basal insulin in vivo.Design and engineering of disulfide crosslinked nanocomplexes of polyamide polyelectrolytes: stability under biorelevant conditions and potent cellular internalization of entrapped model peptide.Novel polyelectrolyte complexes based on poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol) for oral protein delivery.Characterization of hydrogels prepared from copolymerization of the different degrees of methacrylate-grafted chondroitin sulfate macromers and acrylic acidEffect of stoichiometry and pH on the structure and properties of Chitosan/Chondroitin sulfate complexesPrerequisite Characteristics of Nanocarriers Favoring Oral Insulin Delivery: Nanogels as an OpportunityDevelopments in polymeric devices for oral insulin deliveryMucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug deliveryThe oral delivery of proteins using interpolymer polyelectrolyte complexesFabrication and Caffeine Release from Fe3O4/P(MAA-co-NVP) Magnetic Microspheres with Controllable Core–Shell Architecture
P2860
Q27001699-70D5E187-97A0-4BAA-BFB7-9183EC3DDD82Q36047019-CCD496F4-D15C-47B1-9FAE-CFDA93EAD03EQ37039026-96392D1D-2B54-47DF-A67A-356C217A06EEQ37328673-2CD24EE3-FEE3-4F56-8571-86C980668505Q37980520-39DA9FB6-375C-49BE-8546-23E685FB60A1Q38201717-E8F7FCA1-C6BA-4887-A968-B6405959DC64Q38628388-CB9EB6D0-14CC-45A9-91AE-35870C386CDDQ39383421-DD54EBB6-F33F-4CED-9D33-37E6A57FDA5AQ42511424-60119BFA-746A-4267-A4DE-FCBB583A756EQ46780267-657565A3-E0ED-4E9E-B934-9F5175FAABF7Q50891271-389DC902-64D1-458D-B957-7F700B631A84Q57343060-614605F0-819D-4037-802F-EEA304682386Q57343513-800EEC8A-2051-4336-8E86-8D3C8E62AE8DQ57348419-1AB21F8A-24F4-4CFD-889D-9E22E5D5B8AFQ57349681-7D1961EF-094B-4137-AACA-E49845E2CC31Q57349978-D0E202EB-7F27-4BE6-AB48-86961F4FF117Q57350254-B3F29B03-3E49-4900-89C8-53FE01A4C631Q57380455-8E980450-AE13-4F95-87AB-26EC1A872617
P2860
Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Novel pH responsive polymethac ...... les for oral peptide delivery.
@ast
Novel pH responsive polymethac ...... les for oral peptide delivery.
@en
type
label
Novel pH responsive polymethac ...... les for oral peptide delivery.
@ast
Novel pH responsive polymethac ...... les for oral peptide delivery.
@en
prefLabel
Novel pH responsive polymethac ...... les for oral peptide delivery.
@ast
Novel pH responsive polymethac ...... les for oral peptide delivery.
@en
P356
P1476
Novel pH responsive polymethac ...... les for oral peptide delivery.
@en
P2093
P304
P356
10.1002/JBM.B.30372
P577
2006-02-01T00:00:00Z